Change theme to redChange theme to blueChange theme to greenChoose your color
Last Modified Date: 16 Aug 2012
  • |
  • Printer Friendly
  • |
  • Download Adobe Reader
  • |
  • Small Font
  • Medium Font
  • Large Font
 

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil



Antibody technologies
Application No. Date Filed Title
WO 2011/022438 02/24/11 CLEAVAGE SENSITIVE ANTIBODIES AND METHODS OF USE THEREOF

Device technologies
Application No. Date Filed Title
WO/2012/067620 11/18/10 FASTCAST(TM)
2010-0161078 06/24/10 SIMPLIFIED PROSTHETIC DEVICE
2010-0083970 04/08/10 MEDICAL TUBE SECURING DEVICE
2010-0049241 02/25/10 RATCHET HOOK TOURNIQUET
2007-0292829 12/20/07 INTRAVENOUS (IV) TRAINING SYSTEM
2006-0140862 06/29/06 FISH HATCHING METHOD AND APPARATUS
2005-0246903 11/10/05 ERGONOMIC HANDLE FOR A UTILITY KNIFE
2003-0226719 12/11/03 GRAVITY REACTING ANTI-ROLLERBACK BRAKE
2002-0039725 04/04/02 FISH HATCHING METHOD AND APPARATUS
2002-0009119 01/24/02 ENVIRONMENTAL HEAT STRESS MONITOR

Diagnostic technologies
Application No. Date Filed Title
2010-0092938 04/15/10 NOVEL AND PRACTICAL SEROLOGICAL ASSAY FOR THE CLINICAL DIAGNOSIS OF LEISHMANIASIS
2005-0272055 12/08/05 METHOD OF TREATING LETHAL SHOCK INDUCED BY TOXIC AGENTS AND DIAGNOSING EXPOSURE TO TOXIC AGENTS BY MEASURING DISTINCT PATTERN IN THE LEVELS OF EXPRESSION OF SPECIFIC GENES
2005-0033145 02/10/05 WEARABLE TISSUE VIABILITY DIAGNOSTIC UNIT

Method technologies
Application No. Date Filed Title
WO 2011/047241 04/21/11 ENHANCED SUBSTRATES FOR THE PROTEASE ACTIVITY OF SEROTYPE A BOTULINUM NEUROTOXIN
WO 2010/062297 06/03/10 REGENERATIVE TISSUE GRAFTS AND METHODS OF MAKING SAME
WO 2010/045463 04/22/10 CLINICAL DECISION MODEL
2010-0040692 02/18/10 TWO PHASE BIOACTIVE FORMULATIONS
2010-0028386 02/04/10 RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE
2009-0270264 04/09/09 SYSTEM AND METHOD FOR THE DECONVOLUTION OF MIXED DNA PROFILES USING PROPORTIONATELY SHARED ALLELE APPROACH
2007-0218033 09/20/07 COMPOSITION AND METHOD OF TREATING HEPATITIS C
2007-0112275 05/17/07 MEDICAL INTERVENTION INDICATOR METHODS AND SYSTEMS
2005-0205090 09/22/05 AUTOMATED INHALATION TOXICOLOGY EXPOSURE SYSTEM AND METHOD
2005-0074813 04/07/05 MODEL FOR TESTING IMMUNOGENICITY OF PEPTIDES
2004-0005600 01/08/04 METHOD OF DESIGNING SYNTHETIC NUCLEIC ACID SEQUENCES FOR OPTIMAL PROTEIN EXPRESSION IN A HOST CELL
2004-0005681 01/08/04 RAPID METHOD TO MAKE OP DETOXIFYING SPONGES COMPOSED OF MULTIPLE IMMOBILIZED ENZYMES OF CHOLINESTERASES AND OP HYDROLASES AND OXIMES AS REACTIVATORS
2003-0191138 10/09/03 INDOLO [2,1-B] QUINAZOLE-6,12-DIONE ANTIMALARIAL COMPOUNDS AND METHODS OF TREATING MALARIA THEREWITH
2003-0078806 04/24/03 TELEDENTISTRY CONSULT MANAGEMENT SYSTEM AND METHOD
2002-0146160 10/10/02 METHOD AND APPARATUS FOR GENERATING TWO-DIMENSIONAL IMAGES OF CERVICAL TISSUE FROM THREE-DIMENSIONAL HYPERSPECTRAL CUBES
2002-0115678 08/22/02 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIONS

Protein technologies
Application No. Date Filed Title
2003-0118983 06/26/03 RAPID SCREENING PROCEDURE FOR INFLAMMATION MEDIATORS
2003-0082170 05/01/03 PROTEIN FROM BRUCELLA SPECIES

Software technologies
Application No. Date Filed Title
2005-0131738 06/16/05 SYSTEM AND METHOD FOR HANDLING MEDICAL INFORMATION

Therapeutic technologies
Application No. Date Filed Title
2011-0053269 03/03/11 LAMINAR CONSTRUCT FOR TISSUE-ENGINEERED DERMAL EQUIVALENT
2011-0027388 02/03/11 COBALT HEXAMMINE AS A POTENTIAL THERAPEUTIC AGENT AGAINST HIV AND/OR EBOLA VIRUS

Treatment technologies
Application No. Date Filed Title
WO 2011/049659 04/28/11 NOVEL USE AND METHOD OF RAPAMYCIN TO TREAT TOXIC SHOCK
2011-0028349 02/03/11 ENDOTHELIAL MONOCYTE ACTIVATION POLYPEPTIDE II, A BIOMARKER FOR USE IN DIAGNOSIS AND TREATMENT OF BRAIN INJURY
WO 2010/144101 12/16/10 NEXT GENERATION QUINOLOINE METHANOLS
WO 2010/144102 12/16/10 PENTAFLUOROSULFANYL ANALOGS OF MEFLOQUINE
WO 2010/144434 12/16/10 DERIVATIVES OF MEFLOQUINE AND ASSOCIATED METHODS FOR MAKING AND USING
2010-0040640 02/18/10 EXPRESSION, PURIFICATION AND USES OF A PLASMODIUM FALCIPARUM LIVER STAGE ANTIGEN 1 POLYPEPTIDE
2007-0112048 05/17/07 BROAD SPECTRUM ANTIBACTERIAL COMPOUNDS
2007-0072225 03/29/07 ANTIBODIES WITH SIMULTANEOUS SUBSITE SPECIFICITIES TO PROTEIN AND LIPID EPITOPES
2005-0158284 07/21/05 METHOD FOR TREATING, PREVENTING, OR INHIBITING ENTEROTOXIGENIC ESCHERICHIA COLI INFECTIONS WITH BOVINE RED BLOOD CELLS
2005-0113304 05/26/05 PREVINS AS SPECIFIC INHIBITORS AND THERAPEUTIC AGENTS FOR BOTULINUM TOXIN B AND TETANUS NEUROTOXINS
2005-0101907 05/12/05 SYSTEM AND METHOD FOR PROVIDING SERVO-CONTROLLED RESUSCITATION
2005-0009057 01/13/05 ASSAY FOR DETECTING THE PRESENCE OF PROCESSING INHIBITORY ANTIBODIES AGAINST THE APICAL MEMBRANE ANTIGEN-1 OF PLASMODIUM FALCIPARUM IN BIOLOGICAL SAMPLES
2004-0197316 10/07/04 NOVEL METHOD FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
2004-0067205 04/08/04 ACTIVE TOPICAL SKIN PROTECTANTS CONTAINING AMINES, POLYALKENIMINES AND/OR DERIVATIVES
2003-0180341 09/25/03 BIOCOMPATIBLE HYDROPHILIC FILMS FROM POLYMERIC MINI-EMULSIONS FOR APPLICATION TO SKIN
2003-0171424 09/11/03 INTRAVENOUS FORMULATION OF ARTELINIC ACID FOR TREATMENT OF SEVERE AND COMPLICATED MALARIA
2003-0161889 08/28/03 VACCINES AGAINST DISEASES CAUSED BY ENTEROPATHOGENIC ORGANISMS USING ANTIGENS ENCAPSULATED WITHIN BIODEGRADABLE- BIOCOMPATIBLE MICROSPHERES
2003-0157197 08/21/03 PLANT-DERIVED ANTI-PARASITIC AND ANTIFUNGAL COMPOUNDS AND METHODS OF EXTRACTING THE COMPOUNDS
2003-0032578 02/13/03 ANTIFUNGAL AND ANTIPARASITIC COMPOUNDS
2002-0106606 08/08/02 EASY ACCESS DENTAL FIELD OPERATING AND TREATMENT SYSTEM HAVING OVER-THE-PATIENT DELIVERY

Vaccine technologies
Application No. Date Filed Title
WO 2011/056829 05/12/11 AN ORAL VACCINE TO PROTECT ANIMALS AGAINST PLAGUE
WO 2010/062859 06/03/10 RECOMBINANTLY EXPRESSED PLASMODIUM CELTOS ANTIGEN AND METHODS OF USE THEREOF
WO/2009/158142 06/01/09 MENINGOCOCCAL MULTIVALENT NATIVE OUTER MEMBRANE VESICLE VACCINE, METHOD MAKING AND USE THEREOF
2006-0141572 06/29/06 RECOMBINANT LIGHT CHAINS OF BOTULINUM NEUROTOXINS AND LIGHT CHAIN FUSION PROTEINS FOR USE IN RESEARCH AND CLINICAL THERAPY
2006-0099225 05/11/06 GENERATION OF VIRUS-LIKE PARTICLES AND USE AS PANFILOVIRUS VACCINE
2006-0099609 05/11/06 ACTIVATION OF NATURAL KILLER (NK) CELLS AND METHODS OF USE
2006-0002949 01/05/06 TRANSCUTANEOUS IMMUNIZATION WITHOUT HETEROLOGOUS ADJUVANT
2006-0002959 01/05/06 SKIN-ACTIVE ADJUVANTS FOR TRANSCUTANEOUS IMMUNIZATION
2005-0281789 12/22/05 TRANSCUTANEOUS AND/OR TRANSDERMAL TRANSPORT OF MATERIALS
2005-0249755 11/10/05 MUTANT STRAINS OF BRUCELLA MELITENSIS AND IMMUNOGENIC COMPOSITIONS
2004-0047872 06/13/05 INDICATORS FOR MONITORING THE TECHNIQUE OF TRANSCUTANEOUS IMMUNIZATIONS
2005-0009057 01/13/05 ASSAY FOR DETECTING THE PRESENCE OF PROCESSING INHIBITORY ANTIBODIES AGAINST THE APICAL MEMBRANE ANTIGEN-1 OF PLASMODIUM FALCIPARUM IN BIOLOGICAL SAMPLES
2004-0258703 12/23/04 SKIN-ACTIVE ADJUVANTS FOR TRANSCUTANEOUS IMMUNIZATION
2004-0121466 06/24/04 ALPHAVIRUS RNA REPLICON SYSTEMS
2004-0057967 03/25/04 GENERATION OF VIRUS-LIKE PARTICLES AND DEMONSTRATION OF LIPID RAFTS AS SITES OF FILOVIRUS ENTRY AND BUDDING
2003-0185850 10/02/03 PROTECTIVE PEPTIDES NEUROTOXIN OF C. BOTULINUM
2003-0157133 08/21/03 LIPOTEICHOIC ACID IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
2002-0164582 11/07/02 EBOLA VIRION PROTEINS EXPRESSED FROM VENEZUELAN EQUINE ENCEPHALITIS (VEE) VIRUS REPLICONS
2002-0051793 05/02/02 LIPOTEICHOIC ACID IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
2001-0014668 08/16/01 PEPTIDES RESPONSIVE TO ANTIBODIES AGAINST CONSENSUS PEPTIDE OF THE CS4-CFA/I FAMILY PROTEINS

For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil
 

iSalute

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRMC Public Affairs Office at:
usamrmcwebmaster@amedd.army.mil or by telephone at (301)619-2736